Sanofi (SNY) Tops Q1 EPS by 85c; reaffirms guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Sanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy
April 25, 2024 5:30 AM EDTSanofi (NASDAQ: SNY) saw its shares jump 5% in premarket trading Thursday after the company posted better-than-expected business operating profit for the fiscal Q1.
The pharmaceutical company reported Q1 earnings per share (EPS) of EUR 1.78, surpassing the consensus estimate of EUR 0.93. Revenue for the quarter stood at EUR 10.46... More
